Image Credit:Trends in Med Sci
Insights into Background of Microbial Aggregations (Acinetobacter baumannii): A Century of Challenges
Abstract
In recent years, Acinetobacter baumannii has attracted the research community’s attention since they are turned into the leading cause of both community- and hospital-acquired infections. The emergence of MDR-A. baumannii strains threatens hospitalized patients since antibiotics fail to withdraw the bacterial infectious agents. Despite its worldwide distribution, health settings fail to combat limitations in therapeutic regions against A. baumannii. The capability of biofilm formation in A. baumannii strengthens their virulence and also survival. Understanding the fundamental virulence mechanisms beyond the microbial aggregations leads to exploring alternative drug targets such as signaling molecules and Quorum sensing systems to block bacterial communication and antimicrobial resistance. The significance of examining the biofilm's structural details and the relationship between Quorum sensing networks and related signaling molecules has been explicitly highlighted. Accordingly, this review study aimed to explain the general biofilm structure, the mechanisms beyond biofilm formation, quorum sensing system, and the generation of signaling molecules in A. baumannii.
Highlights
Footnotes
Authors' Contribution: Study concept and design: M. M., and N. H. SH.; Search and interpretation of data: N. H. SH., and M. M.; Drafting of the manuscript: N. H. SH. and Y. S A.; Critical revision of the manuscript for important intellectual content: M. M., and N. H. SH; Design and imaging : N. H. SH.
Conflict of Interests: The authors declare no conflict of interests.
Funding/Support: There is no financial support to be declared.
References
- 1.Asif M, Alvi IA, Rehman SU. Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist. 2018;11:1249-60. [PubMed ID: 30174448]. [PubMed Central ID: PMC6110297]. https://doi.org/10.2147/IDR.S166750.
- 2.Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, et al. Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Front Cell Infect Microbiol. 2017;7:55. [PubMed ID: 28348979]. [PubMed Central ID: PMC5346588]. https://doi.org/10.3389/fcimb.2017.00055.
- 3.Mayer C, Muras A, Romero M, Lopez M, Tomas M, Otero A. Multiple Quorum Quenching Enzymes Are Active in the Nosocomial Pathogen Acinetobacter baumannii ATCC17978. Front Cell Infect Microbiol. 2018;8:310. [PubMed ID: 30271754]. [PubMed Central ID: PMC6146095]. https://doi.org/10.3389/fcimb.2018.00310.
- 4.Oh MH, Choi CH. Role of LuxIR Homologue AnoIR in Acinetobacter nosocomialis and the Effect of Virstatin on the Expression of anoR Gene. J Microbiol Biotechnol. 2015;25(8):1390-400. [PubMed ID: 25975610]. https://doi.org/10.4014/jmb.1504.04069.
- 5.Soltani B, Heidari H, Ebrahim-Saraie HS, Hadi N, Mardaneh J, Motamedifar M. Molecular characteristics of multiple and extensive drug-resistant Acinetobacter baumannii isolates obtained from hospitalized patients in Southwestern Iran. Infez Med. 2018;26(1):67-76. [PubMed ID: 29525800].
- 6.Willyard C. The drug-resistant bacteria that pose the greatest health threats. Nature. 2017;543(7643):15. [PubMed ID: 28252092]. https://doi.org/10.1038/nature.2017.21550.
- 7.Lari AR, Azimi L, Motamedifar M, Lari AR. Antibiotic Resistance Patterns and Detection of OXA-23 and OXA-48 Genes in Acinetobacter baumannii Isolated from Ventilator Associated Pneumonia. J Med Bacteriol. 2019;8(3-4):18-22.
- 8.Nie D, Hu Y, Chen Z, Li M, Hou Z, Luo X, et al. Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection. J Biomed Sci. 2020;27(1):26. [PubMed ID: 31954394]. [PubMed Central ID: PMC6969976]. https://doi.org/10.1186/s12929-020-0617-7.
- 9.Modarresi F, Azizi O, Shakibaie MR, Motamedifar M, Mosadegh E, Mansouri S. Iron limitation enhances acyl homoserine lactone (AHL) production and biofilm formation in clinical isolates of Acinetobacter baumannii. Virulence. 2015;6(2):152-61. [PubMed ID: 25622119]. [PubMed Central ID: PMC4601488]. https://doi.org/10.1080/21505594.2014.1003001.
- 10.Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol. 2009;4(3):273-8. [PubMed ID: 19327114]. [PubMed Central ID: PMC2724675]. https://doi.org/10.2217/fmb.09.5.
- 11.Azizi O, Shahcheraghi F, Salimizand H, Modarresi F, Shakibaie MR, Mansouri S, et al. Molecular Analysis and Expression of bap Gene in Biofilm-Forming Multi-Drug-Resistant Acinetobacter baumannii. Rep Biochem Mol Biol. 2016;5(1):62-72. [PubMed ID: 28070537]. [PubMed Central ID: PMC5214686].
- 12.Barceló AM, Cortina IC, Rodríguez AIA, Ballesteros CR. Climatología del Balneario de Villavieja. Anales de la Real Academia Nacional de Farmacia. 2017.
- 13.Zobell CE. The Effect of Solid Surfaces upon Bacterial Activity. J Bacteriol. 1943;46(1):39-56. [PubMed ID: 16560677]. [PubMed Central ID: PMC373789]. https://doi.org/10.1128/jb.46.1.39-56.1943.
- 14.Jones HC, Roth IL, Sanders W3. Electron microscopic study of a slime layer. J Bacteriol. 1969;99(1):316-25. [PubMed ID: 5802613]. [PubMed Central ID: PMC250005]. https://doi.org/10.1128/jb.99.1.316-325.1969.
- 15.Costerton JW, Geesey GG, Cheng KJ. How bacteria stick. Sci Am. 1978;238(1):86-95. [PubMed ID: 635520]. https://doi.org/10.1038/scientificamerican0178-86.
- 16.Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167-93. [PubMed ID: 11932229]. [PubMed Central ID: PMC118068]. https://doi.org/10.1128/CMR.15.2.167-193.2002.
- 17.Greco RS, Prinz FB, Smith R. Nanoscale Technology in Biological Systems. CRC Press; 2004. https://doi.org/10.1201/9780203500224.
- 18.Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol. 1987;41:435-64. [PubMed ID: 3318676]. https://doi.org/10.1146/annurev.mi.41.100187.002251.
- 19.Fletcher M, Loeb GI. Influence of substratum characteristics on the attachment of a marine pseudomonad to solid surfaces. Appl Environ Microbiol. 1979;37(1):67-72. [PubMed ID: 16345338]. [PubMed Central ID: PMC243402]. https://doi.org/10.1128/aem.37.1.67-72.1979.
- 20.Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis. 2001;33(8):1387-92. [PubMed ID: 11565080]. https://doi.org/10.1086/322972.
- 21.Rosenberg M, Bayer EA, Delarea J, Rosenberg E. Role of Thin Fimbriae in Adherence and Growth of Acinetobacter calcoaceticus RAG-1 on Hexadecane. Appl Environ Microbiol. 1982;44(4):929-37. [PubMed ID: 16346118]. [PubMed Central ID: PMC242119]. https://doi.org/10.1128/aem.44.4.929-937.1982.
- 22.Bendinger B, Rijnaarts HH, Altendorf K, Zehnder AJ. Physicochemical cell surface and adhesive properties of coryneform bacteria related to the presence and chain length of mycolic acids. Appl Environ Microbiol. 1993;59(11):3973-7. [PubMed ID: 16349100]. [PubMed Central ID: PMC182562]. https://doi.org/10.1128/aem.59.11.3973-3977.1993.
- 23.Sutherland I. Biofilm exopolysaccharides: a strong and sticky framework. Microbiology (Reading). 2001;147(Pt 1):3-9. [PubMed ID: 11160795]. https://doi.org/10.1099/00221287-147-1-3.
- 24.Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35(4):322-32. [PubMed ID: 20149602]. https://doi.org/10.1016/j.ijantimicag.2009.12.011.
- 25.Hussain M, Wilcox MH, White PJ. The slime of coagulase-negative staphylococci: biochemistry and relation to adherence. FEMS Microbiol Rev. 1993;10(3-4):191-207. [PubMed ID: 8318256]. https://doi.org/10.1111/j.1574-6968.1993.tb05867.x.
- 26.Leriche V, Sibille P, Carpentier B. Use of an enzyme-linked lectinsorbent assay to monitor the shift in polysaccharide composition in bacterial biofilms. Appl Environ Microbiol. 2000;66(5):1851-6. [PubMed ID: 10788349]. [PubMed Central ID: PMC101422]. https://doi.org/10.1128/AEM.66.5.1851-1856.2000.
- 27.Bjarnsholt T, Jensen PO, Fiandaca MJ, Pedersen J, Hansen CR, Andersen CB, et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol. 2009;44(6):547-58. [PubMed ID: 19418571]. https://doi.org/10.1002/ppul.21011.
- 28.Leung KP, Crowe TD, Abercrombie JJ, Molina CM, Bradshaw CJ, Jensen CL, et al. Control of oral biofilm formation by an antimicrobial decapeptide. J Dent Res. 2005;84(12):1172-7. [PubMed ID: 16304449]. https://doi.org/10.1177/154405910508401215.
- 29.Evans DJ, Allison DG, Brown MR, Gilbert P. Effect of growth-rate on resistance of gram-negative biofilms to cetrimide. J Antimicrob Chemother. 1990;26(4):473-8. [PubMed ID: 2254220]. https://doi.org/10.1093/jac/26.4.473.
- 30.Jahangiri S, Malekzadegan Y, Motamedifar M, Hadi N. Virulence genes profile and biofilm formation ability of Acinetobacter baumannii strains isolated from inpatients of a tertiary care hospital in southwest of Iran. Gene Rep. 2019;17. https://doi.org/10.1016/j.genrep.2019.100481.
- 31.Webb JS, Thompson LS, James S, Charlton T, Tolker-Nielsen T, Koch B, et al. Cell death in Pseudomonas aeruginosa biofilm development. J Bacteriol. 2003;185(15):4585-92. [PubMed ID: 12867469]. [PubMed Central ID: PMC165772]. https://doi.org/10.1128/JB.185.15.4585-4592.2003.
- 32.Kobayashi H, Oethinger M, Tuohy MJ, Procop GW, Bauer TW. Improved detection of biofilm-formative bacteria by vortexing and sonication: a pilot study. Clin Orthop Relat Res. 2009;467(5):1360-4. [PubMed ID: 18989729]. [PubMed Central ID: PMC2664413]. https://doi.org/10.1007/s11999-008-0609-5.
- 33.Stickler DJ, Morris NS, McLean RJ, Fuqua C. Biofilms on indwelling urethral catheters produce quorum-sensing signal molecules in situ and in vitro. Appl Environ Microbiol. 1998;64(9):3486-90. [PubMed ID: 9726901]. [PubMed Central ID: PMC106751]. https://doi.org/10.1128/AEM.64.9.3486-3490.1998.
- 34.Hausner M, Wuertz S. High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Appl Environ Microbiol. 1999;65(8):3710-3. [PubMed ID: 10427070]. [PubMed Central ID: PMC91555]. https://doi.org/10.1128/AEM.65.8.3710-3713.1999.
- 35.Anwar H, Costerton JW. Enhanced activity of combination of tobramycin and piperacillin for eradication of sessile biofilm cells of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1990;34(9):1666-71. [PubMed ID: 2126686]. [PubMed Central ID: PMC171902]. https://doi.org/10.1128/AAC.34.9.1666.
- 36.Høiby N, Krogh Johansen H, Moser C, Song Z, Ciofu O, Kharazmi A. Pseudomonas aeruginosa and the in vitroand in vivo biofilm mode of growth. Microbes Infect. 2001;3(1):23-35. https://doi.org/10.1016/s1286-4579(00)01349-6.
- 37.Zhong S, He S. Quorum Sensing Inhibition or Quenching in Acinetobacter baumannii: The Novel Therapeutic Strategies for New Drug Development. Front Microbiol. 2021;12:558003. [PubMed ID: 33597937]. [PubMed Central ID: PMC7882596]. https://doi.org/10.3389/fmicb.2021.558003.
- 38.Modarresi F, Azizi O, Shakibaie MR, Motamedifar M, Valibeigi B, Mansouri S. Effect of iron on expression of efflux pump (adeABC) and quorum sensing (luxI, luxR) genes in clinical isolates of Acinetobacter baumannii. APMIS. 2015;123(11):959-68. [PubMed ID: 26350174]. https://doi.org/10.1111/apm.12455.
- 39.Wu S, Liu J, Liu C, Yang A, Qiao J. Quorum sensing for population-level control of bacteria and potential therapeutic applications. Cell Mol Life Sci. 2020;77(7):1319-43. [PubMed ID: 31612240]. https://doi.org/10.1007/s00018-019-03326-8.
- 40.Bhargava N, Sharma P, Capalash N. Quorum sensing in Acinetobacter: an emerging pathogen. Crit Rev Microbiol. 2010;36(4):349-60. [PubMed ID: 20846031]. https://doi.org/10.3109/1040841X.2010.512269.
- 41.Dou Y, Song F, Guo F, Zhou Z, Zhu C, Xiang J, et al. Acinetobacter baumannii quorum-sensing signalling molecule induces the expression of drug-resistance genes. Mol Med Rep. 2017;15(6):4061-8. [PubMed ID: 28487993]. [PubMed Central ID: PMC5436197]. https://doi.org/10.3892/mmr.2017.6528.
- 42.Niu C, Clemmer KM, Bonomo RA, Rather PN. Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii. J Bacteriol. 2008;190(9):3386-92. [PubMed ID: 18281398]. [PubMed Central ID: PMC2347373]. https://doi.org/10.1128/JB.01929-07.
- 43.Pearson JP, Van Delden C, Iglewski BH. Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals. J Bacteriol. 1999;181(4):1203-10. [PubMed ID: 9973347]. [PubMed Central ID: PMC93498]. https://doi.org/10.1128/JB.181.4.1203-1210.1999.
- 44.Kaplan HB, Greenberg EP. Diffusion of autoinducer is involved in regulation of the Vibrio fischeri luminescence system. J Bacteriol. 1985;163(3):1210-4. [PubMed ID: 3897188]. [PubMed Central ID: PMC219261]. https://doi.org/10.1128/jb.163.3.1210-1214.1985.
- 45.Defoirdt T. Quorum-Sensing Systems as Targets for Antivirulence Therapy. Trends Microbiol. 2018;26(4):313-28. [PubMed ID: 29132819]. https://doi.org/10.1016/j.tim.2017.10.005.
- 46.Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ. The biology and future prospects of antivirulence therapies. Nat Rev Microbiol. 2008;6(1):17-27. [PubMed ID: 18079741]. [PubMed Central ID: PMC2211378]. https://doi.org/10.1038/nrmicro1818.
- 47.Clatworthy AE, Pierson E, Hung DT. Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol. 2007;3(9):541-8. [PubMed ID: 17710100]. https://doi.org/10.1038/nchembio.2007.24.
- 48.Deng Y, Wu J, Tao F, Zhang LH. Listening to a new language: DSF-based quorum sensing in Gram-negative bacteria. Chem Rev. 2011;111(1):160-73. [PubMed ID: 21166386]. https://doi.org/10.1021/cr100354f.
- 49.Anbazhagan D, Mansor M, Yan GO, Md Yusof MY, Hassan H, Sekaran SD. Detection of quorum sensing signal molecules and identification of an autoinducer synthase gene among biofilm forming clinical isolates of Acinetobacter spp. PLoS One. 2012;7(7). e36696. [PubMed ID: 22815678]. [PubMed Central ID: PMC3398020]. https://doi.org/10.1371/journal.pone.0036696.
- 50.Kang YS, Park W. Contribution of quorum-sensing system to hexadecane degradation and biofilm formation in Acinetobacter sp. strain DR1. J Appl Microbiol. 2010;109(5):1650-9. [PubMed ID: 20629796]. https://doi.org/10.1111/j.1365-2672.2010.04793.x.
- 51.Chow JY, Yang Y, Tay SB, Chua KL, Yew WS. Disruption of biofilm formation by the human pathogen Acinetobacter baumannii using engineered quorum-quenching lactonases. Antimicrob Agents Chemother. 2014;58(3):1802-5. [PubMed ID: 24379199]. [PubMed Central ID: PMC3957888]. https://doi.org/10.1128/AAC.02410-13.
- 52.Kooti S, Motamedifar M, Sarvari J. Antibiotic Resistance Profile and Distribution of Oxacillinase Genes Among Clinical Isolates of Acinetobacter baumannii in Shiraz Teaching Hospitals, 2012 - 2013. Jundishapur J Microbiol. 2015;8(8). https://doi.org/10.5812/jjm.20215v2.
- 53.Fernandez-Garcia L, Ambroa A, Blasco L, Bleriot I, Lopez M, Alvarez-Marin R, et al. Relationship Between the Quorum Network (Sensing/Quenching) and Clinical Features of Pneumonia and Bacteraemia Caused by A. baumannii. Front Microbiol. 2018;9:3105. [PubMed ID: 30619184]. [PubMed Central ID: PMC6304438]. https://doi.org/10.3389/fmicb.2018.03105.
- 54.Lopez M, Rueda A, Florido JP, Blasco L, Fernandez-Garcia L, Trastoy R, et al. Evolution of the Quorum network and the mobilome (plasmids and bacteriophages) in clinical strains of Acinetobacter baumannii during a decade. Sci Rep. 2018;8(1):2523. [PubMed ID: 29410443]. [PubMed Central ID: PMC5802823]. https://doi.org/10.1038/s41598-018-20847-7.
- 55.LaSarre B, Federle MJ. Exploiting quorum sensing to confuse bacterial pathogens. Microbiol Mol Biol Rev. 2013;77(1):73-111. [PubMed ID: 23471618]. [PubMed Central ID: PMC3591984]. https://doi.org/10.1128/MMBR.00046-12.
- 56.Hung DT, Shakhnovich EA, Pierson E, Mekalanos JJ. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science. 2005;310(5748):670-4. [PubMed ID: 16223984]. https://doi.org/10.1126/science.1116739.
- 57.Shakhnovich EA, Hung DT, Pierson E, Lee K, Mekalanos JJ. Virstatin inhibits dimerization of the transcriptional activator ToxT. Proc Natl Acad Sci U S A. 2007;104(7):2372-7. [PubMed ID: 17283330]. [PubMed Central ID: PMC1892951]. https://doi.org/10.1073/pnas.0611643104.
- 58.Desbois AP, Lawlor KC. Antibacterial activity of long-chain polyunsaturated fatty acids against Propionibacterium acnes and Staphylococcus aureus. Mar Drugs. 2013;11(11):4544-57. [PubMed ID: 24232668]. [PubMed Central ID: PMC3853744]. https://doi.org/10.3390/md11114544.
- 59.Desbois AP, Smith VJ. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol. 2010;85(6):1629-42. [PubMed ID: 19956944]. https://doi.org/10.1007/s00253-009-2355-3.
- 60.Berge JP, Barnathan G. Fatty acids from lipids of marine organisms: molecular biodiversity, roles as biomarkers, biologically active compounds, and economical aspects. Adv Biochem Eng Biotechnol. 2005;96:49-125. [PubMed ID: 16566089]. https://doi.org/10.1007/b135782.
- 61.Nicol M, Alexandre S, Luizet JB, Skogman M, Jouenne T, Salcedo SP, et al. Unsaturated Fatty Acids Affect Quorum Sensing Communication System and Inhibit Motility and Biofilm Formation of Acinetobacter baumannii. Int J Mol Sci. 2018;19(1). [PubMed ID: 29320462]. [PubMed Central ID: PMC5796163]. https://doi.org/10.3390/ijms19010214.
- 62.Nait Chabane Y, Mlouka MB, Alexandre S, Nicol M, Marti S, Pestel-Caron M, et al. Virstatin inhibits biofilm formation and motility of Acinetobacter baumannii. BMC Microbiol. 2014;14:62. [PubMed ID: 24621315]. [PubMed Central ID: PMC4007623]. https://doi.org/10.1186/1471-2180-14-62.
- 63.Lowden MJ, Skorupski K, Pellegrini M, Chiorazzo MG, Taylor RK, Kull FJ. Structure of Vibrio cholerae ToxT reveals a mechanism for fatty acid regulation of virulence genes. Proc Natl Acad Sci U S A. 2010;107(7):2860-5. [PubMed ID: 20133655]. [PubMed Central ID: PMC2840316]. https://doi.org/10.1073/pnas.0915021107.
Copyright
Copyright © 2021, Trends in Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Similar Articles
Assessment of Biofilm Formation and Resistance to Imipenem and Ciprofloxacin among Clinical Isolates of Acinetobacter baumannii in Tehran
Abdi-Ali A, Hendiani S, Mohammadi P, Gharavi S. Assessment of Biofilm Formation and Resistance to Imipenem and Ciprofloxacin among Clinical Isolates of Acinetobacter baumannii in Tehran. Jundishapur J Microbiol. 2014;7(1):e8606. doi: https://doi.org/10.5812/jjm.8606
Phenotypic and Genotypic Investigation of Biofilm Formation in Clinical and Environmental Isolates of Acinetobacter baumannii
Ghasemi E, Ghalavand Z, Goudarzi H, Yeganeh F, Hashemi A, et al. Phenotypic and Genotypic Investigation of Biofilm Formation in Clinical and Environmental Isolates of Acinetobacter baumannii. Arch Clin Infect Dis. 2018;13(4):e12914. doi: https://doi.org/10.5812/archcid.12914
Confrontation with Acinetobacter Baumannii by Exploiting its Biofilm: An Insight to Vaccine Development
Fattahian Y, Rasooli I, Mousavi Gargari SL, Sandstrm G, Rahbar MR, et al. Confrontation with Acinetobacter Baumannii by Exploiting its Biofilm: An Insight to Vaccine Development. Arch Clin Infect Dis. 2012;7(1):. doi:
Correlation of Virulence Factors and Cell Adhesion of Clinical Isolates of Acinetobacter baumannii
Afshar Payam M, Rasooli I, Owlia P, Talei D, Darvish Alipour Astaneh S, et al. Correlation of Virulence Factors and Cell Adhesion of Clinical Isolates of Acinetobacter baumannii. Arch Clin Infect Dis. 2018;13(3):e62841. doi: https://doi.org/10.5812/archcid.62841
Detection of Genes Involved in Biofilm Formation in MDR and XDR Acinetobacter baumannii Isolated from Human Clinical Specimens in Isfahan, Iran
Mahmoudi Monfared A, Rezaei A, Poursina F, Faghri J. Detection of Genes Involved in Biofilm Formation in MDR and XDR Acinetobacter baumannii Isolated from Human Clinical Specimens in Isfahan, Iran. Arch Clin Infect Dis. 2019;14(2):e85766. doi: https://doi.org/10.5812/archcid.85766
More by these authors
- Scopus by DOI: 0
Last Update: 1 day ago
- Scopus by Title: 0
Last Update: 1 day ago
- Scopus by Title (Ref): 1
Last Update: 1 day ago
- CrossRef: 0
Last Update: 1 day ago
- OpenAlex: 0
Last Update: 20 hours ago
- OpenCitations: 0
Last Update: 5 days ago

